IMCY-0141

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIMCY-0141
Drug Alias NameIMCY-0141
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionT-cell surface antigen CD4 agonists
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-Remitting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMoldova, Republic of
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImcyse Sa
China Registration ClassN/A

Develop Information

Active CompaniesImcyse Sa
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis, Relapsing-Remitting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A